Nov 12th, 2018 - Researchers have reported for the first time that they have found inflammation in the brains of patients with fibromyalgia. Daniel S. Albrecht, PhD, a postdoctoral fellow with the Department of Radiology at Massachusetts General Hospital, and Harvard Medical School, Boston, and colleagues, joined with a research team led by Anton Forsberg, PhD, of the Department of Clinical Neuroscience at the ...
Nov 12th, 2018 - Comorbidities increase disease activity regardless of race/ethnicity or medication use among patients with rheumatoid arthritis
Nov 12th, 2018 - Patients with moderate to severe rheumatoid arthritis experienced onset of efficacy sooner when treatment with baricitinib started earlier vs. later, although improvement in overall disease activity was similar among patients who received earlier vs. later treatment, according to findings presented at the ACR/ARHP 2018 Annual Meeting.
Nov 12th, 2018
Nov 9th, 2018 - CHICAGO – The American College of Rheumatology is continuing to work on its physician-focused advanced alternative payment model (APM) pathway for RA, with hopes to send the fully developed model to the Physician-Focused Payment Model Technical Advisory Committee once financial data gathering and analysis is complete, followed by pilot testing once it is accepted by the Centers for Medicare & M.
Nov 9th, 2018 - Ixekizumab was superior to placebo in reducing disease activity while improving function, as well as spinal and sacroiliac joint
Nov 8th, 2018 - Researchers developed three algorithms that successfully identified patients with axial spondyloarthritis
Nov 8th, 2018 - I always look forward to the ACR yearly review course for an engaging way to get updates on various topics in the field of rheumatology.
Nov 8th, 2018 - Research presented at the ACR/ARHP 2018 Annual Meeting showed that secukinumab, a treatment for ankylosing spondylitis
Nov 8th, 2018 - Patients with high-risk systemic lupus erythematosus have a lower risk for hospitalization and a shorter length of stay
Nov 7th, 2018 - CHICAGO – The commercially available multibiomarker disease activity score assay and power Doppler ultrasound at baseline in rheumatoid arthritis patients treated with tofacitinib predicted 12-week responses on some clinical, imaging, and biomarker endpoints, according to findings from an investigator-initiated, open-label study. Dr.
Mitchel L. Zoler
Nov 7th, 2018 - CHICAGO – New draft guidelines for treating juvenile idiopathic arthritis (JIA) written by experts assembled by the American College of Rheumatology “formalize inactive disease as the goal of treatment,” Timothy G. Beukelman, MD, said at the annual meeting of the American College of Rheumatology.
Nov 7th, 2018 - CHICAGO – Discontinuing methotrexate for 2 weeks in patients with RA starting the day they receive the seasonal influenza vaccine significantly improves the vaccine’s immunogenicity without aggravating disease activity, Kevin L. Winthrop, MD, reported at the annual meeting of the American College of Rheumatology.
Nov 7th, 2018 - Lupus nephritis is recurring less frequently among patients with end-stage renal disease who undergo kidney transplant
Nov 7th, 2018 - Analysis of bone marrow edema, including the anatomical location, may help differentiate axial spondyloarthritis
Mitchel L. Zoler
Nov 6th, 2018 - CHICAGO – Subgroup categorization of patients with severe scleroderma by their gene-expression profile correlated with responses to a newly proven treatment for the disease that involves myeloablation and autologous hematopoietic stem cell transplantation (HSCT). Dr.
Nov 6th, 2018 - CHICAGO – Newer isn’t necessarily better – especially when it comes to the plethora of SLE classification criteria, according to Michelle A. Petri, MD, professor of medicine and director of the Hopkins Lupus Center at Johns Hopkins University, Baltimore.
Nov 6th, 2018 - A “culturally competent” and well-designed online resource, called “Be Fierce. Take Control,” was successful in raising awareness of systemic lupus erythematosus among at-risk populations, including young black and Latina women, according to data presented at the ACR/ARHP 2018 Annual Meeting by R. Paola Daly, MPH, of the Lupus Foundation of America
Nov 6th, 2018 - A diagnosis of IgG4-related disease must take into account a variety of factors, including the patient’s clinical presentation
Nov 5th, 2018 - NEW YORK (Reuters Health) - Ixekizumab improves signs and symptoms in patients with radiographic axial spondyloarthritis (ankylosing spondylitis), according to results from the COAST-W study. "Ankylosing spondylitis is a chronic and debilitating disease, and I have a large number of patients who have failed TNF inhibitors," said Dr. Atul Deodhar from Oregon Health and Science University, in Por...